Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Other financing activities: 2013-2025

Historic Other financing activities for Amphastar Pharmaceuticals (AMPH) over the last 4 years, with Sep 2025 value amounting to $4,000.

  • Amphastar Pharmaceuticals' Other financing activities fell 99.32% to $4,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $657,000, marking a year-over-year decrease of 50.53%. This contributed to the annual value of $816,000 for FY2024, which is 96.75% down from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Other financing activities is $4,000, which was down 98.42% from $253,000 recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Other financing activities ranged from a high of $10.4 million in Q3 2023 and a low of -$22,000 during Q4 2024.
  • In the last 3 years, Amphastar Pharmaceuticals' Other financing activities had a median value of $253,000 in 2025 and averaged $1.4 million.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Other financing activities slumped by 104.49% in 2024 and then skyrocketed by 25,400.00% in 2025.
  • Amphastar Pharmaceuticals' Other financing activities (Quarterly) stood at $308,000 in 2021, then plummeted by 99.03% to $3,000 in 2022, then surged by 16,233.33% to $490,000 in 2023, then tumbled by 104.49% to -$22,000 in 2024, then tumbled by 99.32% to $4,000 in 2025.
  • Its Other financing activities stands at $4,000 for Q3 2025, versus $253,000 for Q2 2025 and $422,000 for Q1 2025.